|
Quotes & Info
|
| BJCT.OB > SEC Filings for BJCT.OB > Form 8-K on 10-Nov-2008 | All Recent SEC Filings |
10-Nov-2008
Results of Operations and Financial Condition, Financial Stateme
On November 10, 2008, Bioject Medical Technologies Inc. ("Bioject") issued a press release announcing a net loss allocable to common shareholders of $1.1 million, or $0.07 per share, on revenues of $1.7 million for its third quarter ended September 30, 2008. Bioject also announced a net loss allocable to common shareholders of $2.8 million, or $0.18 per share, on revenues of $5.1 million for the nine-month period ended September 30, 2008. A copy of the press release is attached as Exhibit 99.1.
(d) Exhibits
The following exhibit is furnished herewith and this list is intended to constitute the exhibit index:
99.1 Press release dated November 10, 2008 announcing Bioject Medical
Technologies Inc.'s results for its third quarter ended September 30,
2008.
|
|
|